Haemonetics Corporation (HAE) Social Stream



Haemonetics Corporation (HAE): $67.32

2.14 (+3.28%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Haemonetics Corp (HAE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Haemonetics Corp.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 8 $108 $68 $81.571 $61.5 32.64%
2021-11-10 8 $108 $68 $78.428 $61.5 27.53%
2022-01-06 8 $108 $59 $76 $61.5 23.58%
2022-01-07 8 $108 $59 $74.857 $61.5 21.72%
2022-02-08 7 $108 $59 $74.285 $61.5 20.79%
2022-02-09 8 $108 $59 $75.428 $61.5 22.65%

The Trend in the Analyst Price Target


Over the past 41 weeks, HAE's average price target has gone down $42.

Over the past 45 weeks, HAE's average upside potential has been 36.55%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-24 6 90 71 80.290 59.06 35.95%
2021-09-04 7 90 68 79.250 64.57 22.74%
2021-09-19 7 90 68 79.250 70.22 12.86%
2021-11-10 8 108 67 78.285 61.51 27.27%
2022-02-09 8 108 59 75.428 56.92 32.52%

HAE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.88 4 1 3 0 0 8

The Trend in the Broker Recommendations


HAE's average broker recommendation rating worsened by 0.13 over the prior 123 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • HAE has a lower variance in analysts' estimates than -497.59% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, Haemonetics Corp's upside potential (average analyst target price relative to current price) is greater than 167.72% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, Haemonetics Corp's average analyst price target is greater than 602.38% of them.
  • HAE has a greater number of analysts covering the stock than 502.98% of Healthcare stocks.

In the Medical Equipment industry, GMED, GKOS, and ATRC are the three stocks most similar to Haemonetics Corp regarding the price target and analyst recommendation information presented here.

Is HAE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4892 seconds.